| [1] |
Khan SA, Emadossadaty S, Ladep NG, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?[J]. J Hepatol, 2012, 56(4):848-854.
|
| [2] |
Choi ER, Chung YH, Lee JK, et al. Preoperative evaluation of the longitudinal extent of borderline resectable hilar cholangiocarcinoma by intraductal ultrasonography[J]. J Gastroenterol Hepatol, 2011, 26(12):1804-1810.
|
| [3] |
Deoliveira ML, Schulick RD, Nimura Y, et al. New staging system and a registry for perihilar cholangiocarcinoma[J]. Hepatology, 2011, 53(4):1363-1371.
|
| [4] |
王彦冬，经翔，王毅军，等．三维超声联合超声造影对肝门胆管癌可切除性评估的研究[J]．肿瘤影像学，2014(1):24-28.
|
| [5] |
Andert A, Bruners P, Heidenhain C, et al. Impact of preoperative three-dimensional computed tomography cholangiography on postoperative resection margin status in patients operated due to hilar cholangiocarcinoma[J]. Gastroenterol Res Pract, 2017:1947023.
|
| [6] |
邹俊民，陈培龙，谢淑飞，等．肝门胆管癌多层螺旋CT诊断及其手术可切除性评估价值研究[J]．中国实用外科杂志，2011(12):1110-1113.
|
| [7] |
Park MJ, Kim YK, Lim S, et al. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation[J]. Radiology, 2014, 270(3):768-776.
|
| [8] |
Radtke A, Königsrainer A. Surgical therapy of cholangiocarcinoma[J]. Visc Med, 2016, 32(6):422-426.
|
| [9] |
Parodi A, Fisher D, Giovannini M, et al. Endoscopic management of hilar cholangiocarcinoma[J]. Nat Rev Gastroenterol Hepatol, 2012, 9(2):105-112.
|
| [10] |
Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma[J]. J Gastroenterol Hepatol, 2013, 28(4):593-607.
|
| [11] |
Zhimin G, Noor H, Jian-Bo Z, et al. Advances in diagnosis and treatment of hilar cholangiocarcinoma--a review[J]. Med Sci Monit, 2013(19):648-656.
|
| [12] |
Ruys AT, Bennink RJ, van Westreenen HL, et al. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma[J]. HPB, 2011, 13(4):256-262.
|
| [13] |
Fattach HE, Dohan A, Guerrache Y, et al. Intrahepatic and hilar mass-forming cholangiocarcinoma: qualitative and quantitative evaluation with diffusion-weighted MR imaging[J]. Eur J Radiol, 2015, 84(8):1444-1451.
|
| [14] |
孙备，刘欢．肝门胆管癌的术前可切除性评估[J]．中国普外基础与临床杂志，2014(3):268-272.
|
| [15] |
晏益核，黄玉斌．肝门部胆管癌的外科治疗现状[J]．中国普通外科杂志，2017,26(2):246-251.
|
| [16] |
中华外科杂志编辑部．肝门部胆管癌外科治疗的若干热点问题[J]．中华外科杂志，2013,51(11):961-978.
|
| [17] |
潘龙，杜成友，李德卫．吲哚菁绿排泄实验在门静脉高压症择期手术中的意义[J]．重庆医科大学学报，2014,38(7):1041-1044.
|
| [18] |
张珂，蒋力，穆毅，等．吲哚氰绿试验联合血栓弹力图补充Child-Pugh分级在评估门脉高压手术患者肝储备功能中的应用[J]．实用医学杂志，2010,26(9):1475-1478.
|
| [19] |
Itoh S, Yoshizumi T, Shirabe K, et al. Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma[J]. Hepatol Res, 2017, 47(5):398-404.
|